Science Explorer Back to mapMap
Discussion
Hospital / health system · Saitama · Japan

Saitama Cancer Center

In research, Saitama Cancer Center stands highest in Health Sciences (#5,726 of 9,902 worldwide) and Medicine (#5,155 of 8,541 worldwide), 2022-now. Relative to its size it is most specialised in Oncology, Pulmonary and Respiratory Medicine and Surgery (Oncology is 16.5× its share of world research).

pref.saitama.lg.jp/saitama-ccROR OpenAlex
World rank, 2022-now
#19,873
of 22,385 · #26,139 all time
Rank in Japan
#667
of 924
Research works
1.7k
▲ 15% vs 2018-21
Citations
49k
29.1 per fractional work
Top-10% rate
6.9%
all institutions 10.0%
vs its own fields
0.92×
1.00× is exactly expected
Open access
39%
world 40%
International
8%
world 18%
Saitama Cancer Center

What is Saitama Cancer Center known for in research?

The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Health SciencesDomain #5,726 of 9,902 6.2%136 #10530
MedicineField #5,155 of 8,541 6.1%134 #9171

Each strip is that field's whole ranked pool, with the notch where Saitama Cancer Center sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Saitama Cancer Center work in?

In 2022-now, 83% of research at Saitama Cancer Center is in Health Sciences, 14% in Life Sciences. Its largest fields are Medicine (82%), Biochemistry, Genetics and Molecular Biology (12%), Engineering (1%). It does 3.4× the world's share of Health Sciences.

Health Sciences: 152 fractional works · 83.3% of its workMedicine: 151 fractional works · 82.4% of its workOncology: 34 fractional works · 18.6% of its workSurgery: 32 fractional works · 17.5% of its workPulmonary and Respiratory Medicine: 28 fractional works · 15.3% of its workPathology and Forensic Medicine: 8 fractional works · 4.6% of its workRadiology, Nuclear Medicine and Imaging: 5 fractional works · 2.8% of its workNeurology: 5 fractional works · 2.7% of its workEpidemiology: 5 fractional works · 2.7% of its workRheumatology: 3 fractional works · 1.8% of its workHematology: 3 fractional works · 1.7% of its workGenetics: 3 fractional works · 1.6% of its workObstetrics and Gynecology: 3 fractional works · 1.6% of its workOtorhinolaryngology: 2 fractional works · 1.3% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 1.0% of its workReproductive Medicine: 2 fractional works · 1.0% of its workGastroenterology: 2 fractional works · 1.0% of its workPhysiology: 2 fractional works · 1.0% of its workHepatology: 2 fractional works · 0.9% of its workCardiology and Cardiovascular Medicine: 2 fractional works · 0.8% of its workDermatology: 1 fractional works · 0.8% of its workInfectious Diseases: 1 fractional works · 0.6% of its workPsychiatry and Mental health: 1 fractional works · 0.6% of its workAnesthesiology and Pain Medicine: 1 fractional works · 0.4% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 0.3% of its workGeriatrics and Gerontology: 1 fractional works · 0.3% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.3% of its workNephrology: 0 fractional works · 0.2% of its workSmaller subfields together: 2 fractional works · 1.2% of its workHealth Professions: 1 fractional works · 0.4% of its workPharmacy: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workDentistry: 1 fractional works · 0.4% of its workOral Surgery: 1 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workNursing: 0 fractional works · 0.2% of its workLife Sciences: 25 fractional works · 13.8% of its workBiochemistry, Genetics and Molecular Biology: 22 fractional works · 12.0% of its workMolecular Biology: 12 fractional works · 6.6% of its workCancer Research: 7 fractional works · 3.7% of its workGenetics: 2 fractional works · 1.1% of its workCell Biology: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.3% of its workImmunology and Microbiology: 2 fractional works · 0.9% of its workImmunology: 2 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 1 fractional works · 0.4% of its workNeurology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 1 fractional works · 0.3% of its workPlant Science: 1 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.2% of its workPhysical Sciences: 4 fractional works · 2.2% of its workEngineering: 2 fractional works · 1.0% of its workBiomedical Engineering: 2 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPhysics and Astronomy: 1 fractional works · 0.5% of its workRadiation: 1 fractional works · 0.5% of its workComputer Science: 1 fractional works · 0.3% of its workArtificial Intelligence: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workChemistry: 0 fractional works · 0.2% of its workMaterials Science: 0 fractional works · 0.1% of its workEnvironmental Science: 0 fractional works · 0.0% of its workSocial Sciences: 1 fractional works · 0.7% of its workSocial Sciences: 1 fractional works · 0.3% of its workSociology and Political Science: 1 fractional works · 0.3% of its workDecision Sciences: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.1% of its workPsychology: 0 fractional works · 0.1% of its workALL ITS WORKSaitama CancerCenter183fractional works, 2022-now
Life Sciences14%Physical Sciences2%Health Sciences83%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 20 fields, with their numbers
    1. Medicine15182.4%
    2. Health Professions10.4%
    3. Dentistry10.4%
    4. Nursing00.2%
    1. Biochemistry, Genetics and Molecular Biology2212.0%
    2. Immunology and Microbiology20.9%
    3. Neuroscience10.4%
    4. Agricultural and Biological Sciences10.3%
    5. Pharmacology, Toxicology and Pharmaceutics00.2%
    1. Engineering21.0%
    2. Physics and Astronomy10.5%
    3. Computer Science10.3%
    4. Chemistry00.2%
    5. Materials Science00.1%
    6. Environmental Science00.0%
    7. Mathematics00.0%
    1. Social Sciences10.3%
    2. Decision Sciences00.2%
    3. Economics, Econometrics and Finance00.1%
    4. Psychology00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Saitama Cancer Center specialise in?

Where its research is concentrated relative to its size: Oncology takes 16.5× the share of its output that it takes of world research.

  1. OncologySubfield · 34.0 works16×
  2. Pulmonary and Respiratory MedicineSubfield · 27.9 works9.9×
  3. SurgerySubfield · 32.0 works7.5×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.07× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.26× its world share, 22 worksBiochemistry, Geneti…Immunology and Microbiology: 0.94× its world share, 2 worksImmunology and Micro…Neuroscience: 0.22× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.49× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.15× its world share, 0 worksChemistryComputer Science: 0.04× its world share, 0 worksComputer ScienceEngineering: 0.06× its world share, 2 worksEngineeringEnvironmental Science: 0.01× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.04× its world share, 0 worksMaterials ScienceMathematics: 0.01× its world share, 0 worksMathematicsPhysics and Astronomy: 0.21× its world share, 1 worksPhysics and AstronomyDentistry: 0.73× its world share, 1 worksDentistryHealth Professions: 0.16× its world share, 1 worksHealth ProfessionsMedicine: 4.28× its world share, 151 worksMedicineNursing: 0.31× its world share, 0 worksNursingDecision Sciences: 0.19× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.06× its world share, 0 worksEconomics, Econometr…Psychology: 0.04× its world share, 0 worksPsychologySocial Sciences: 0.02× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.3×. Every wedge is a field page.

All 20 fields, with their numbers
  1. Medicine4.28×151 works
  2. Biochemistry, Genetics and Molecular Biology2.26×22 works
  3. Immunology and Microbiology0.94×2 works
  4. Dentistry0.73×1 works
  5. Pharmacology, Toxicology and Pharmaceutics0.49×0 works
  6. Nursing0.31×0 works
  7. Neuroscience0.22×1 works
  8. Physics and Astronomy0.21×1 works
  9. Decision Sciences0.19×0 works
  10. Health Professions0.16×1 works
  11. Chemistry0.15×0 works
  12. Agricultural and Biological Sciences0.07×1 works
  13. Engineering0.06×2 works
  14. Economics, Econometrics and Finance0.06×0 works
  15. Computer Science0.04×0 works
  16. Materials Science0.04×0 works
  17. Psychology0.04×0 works
  18. Social Sciences0.02×1 works
  19. Environmental Science0.01×0 works
  20. Mathematics0.01×0 works

Who are the top researchers at Saitama Cancer Center?

Ranked on the quality score, Osamu Gotoh, Hiroki Hara and Masami Suganuma lead among researchers whose main affiliation is Saitama Cancer Center.

  1. 1 Osamu Gotoh Japan · #347,032 worldwide 14k citations · 168 works
  2. 2 Hiroki Hara Japan · #354,853 worldwide 17k citations · 489 works
  3. 3 Masami Suganuma Japan · #752,941 worldwide 12k citations · 245 works
  4. 4 Kaname Kawajiri Japan · #919,561 worldwide 7.3k citations · 83 works
  5. 5 Hideaki Mizutani Japan · #1,240,967 worldwide 1.4k citations · 51 works
  6. 6 Sachiko Okabe Japan · #1,306,651 worldwide 4.9k citations · 107 works
  7. 7 Naoki Takahashi Japan · #1,516,108 worldwide 3.1k citations · 229 works
  8. 8 Yasutaka Watanabe Japan · #1,757,830 worldwide 1.8k citations · 75 works
  9. 9 Hiroki Tsutsumi Japan · #1,968,012 worldwide 238 citations · 31 works
  10. 10 Hirota Fujiki Japan · #2,160,572 worldwide 18k citations · 388 works
All ranked researchers at Saitama Cancer Center

What are the most cited papers from Saitama Cancer Center?

The most cited paper from Saitama Cancer Center is "The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology" (N.K. Aaronson, Sam Hjelmeland Ahmedzai, Bengt Bergman et al., 1993), with 16,252 citations. Next come "Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer" (2,901) and "Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer" (2,660).

Most cited papers
#PaperReleasedCitations
1 The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology N.K. Aaronson, Sam Hjelmeland Ahmedzai, Bengt Bergman et al. · JNCI Journal of the National Cancer Institute 3 Mar 1993 16,252
2 Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer Matthew David Hellmann et al. · New England Journal of Medicine Open access 28 Sep 2019 2,901
3 Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer Fabrice André, Eva M. Ciruelos, Gábor Rubovszky et al. · New England Journal of Medicine Open access 15 May 2019 2,660
4 An improved algorithm for matching biological sequences Osamu Gotoh · Journal of Molecular Biology Dec 1982 1,777
5 Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study Jong‐Mu Sun et al. · The Lancet Open access Aug 2021 1,679
All 60 most cited papers, with filters and sorting

Which keywords describe research at Saitama Cancer Center?

By fractional works in 2022-now, weighted toward what it does more of than the world: Chemotherapy, Neoadjuvant Therapy, Endoscopic Resection, Clinical Practice Guidelines, Tumor Microenvironment, Prognostic Factors, Molecular Characterization and Immunotherapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy34▲ 26×21 topics
  2. Neoadjuvant Therapy18▲ 42×5 topics
  3. Endoscopic Resection18▲ 100×2 topics
  4. Clinical Practice Guidelines18▲ 18×10 topics
  5. Tumor Microenvironment16▲ 20×7 topics
  6. Epidemiology15▲ 2.1×30 topics
  7. Prognostic Factors15▲ 19×14 topics
  8. Molecular Characterization15▲ 47×4 topics
  9. Immunotherapy15▲ 11×16 topics
  10. Survival Analysis14▲ 27×6 topics
  11. Chemoradiation11▲ 94×2 topics
  12. Preoperative Chemoradiotherapy11▲ 76×2 topics
  13. Radiotherapy11▲ 15×12 topics
  14. Surgery11▲ 17×4 topics
  15. Adjuvant Therapy10▲ 46×2 topics
  16. Gastric Cancer10▲ 51×3 topics
  17. Cancer10▲ 4.0×31 topics
  18. Barrett's Esophagus10▲ 125×1 topic
  19. Esophageal Carcinoma10▲ 125×1 topic
  20. Targeted Therapy9▲ 23×4 topics
  21. Breast Cancer9▲ 20×9 topics
  22. Neoadjuvant Chemotherapy9▲ 57×2 topics
  23. Lymph Node Dissection9▲ 81×1 topic
  24. Metastatic Gastric Cancer9▲ 81×1 topic
  25. Immune Checkpoint Blockade8▲ 40×1 topic
  26. PD-1 and PD-L18▲ 40×1 topic
  27. Clinical Trials8▲ 6.4×5 topics
  28. Genetic Mutations7▲ 9.0×11 topics
  29. Molecular Profiling7▲ 41×3 topics
  30. Precision Medicine7▲ 7.5×4 topics
  31. Metastasis7▲ 11×11 topics
  32. Cetuximab6▲ 40×2 topics
  33. Prognosis6▲ 9.9×6 topics
  34. Rituximab6▲ 22×4 topics
  35. PET Imaging6▲ 19×4 topics
  36. Molecular Subtypes5▲ 34×3 topics
  37. Surgical Management5▲ 7.3×9 topics
  38. Prognostic Markers5▲ 26×3 topics
  39. Therapeutic Targets5▲ 19×5 topics
  40. Gene Expression Profiling5▲ 33×2 topics

Which research topics does Saitama Cancer Center publish most on?

By volume in 2022-now: Esophageal Cancer Research and Treatment, Gastric Cancer Management and Outcomes, Cancer Immunotherapy and Biomarkers and Lung Cancer Treatments and Mutations.

Esophageal Cancer Research and Treatment: 10 fractional worksGastric Cancer Management and Outcomes: 9 fractional worksCancer Immunotherapy and Biomarkers: 8 fractional worksLung Cancer Treatments and Mutations: 4 fractional worksColorectal Cancer Treatments and Studies: 4 fractional worksLymphoma Diagnosis and Treatment: 3 fractional worksCancer Genomics and Diagnostics: 3 fractional worksGenetic factors in colorectal cancer: 3 fractional worksPancreatic and Hepatic Oncology Research: 3 fractional worksChronic Lymphocytic Leukemia Research: 2 fractional works
SurgeryPulmonary and Respiratory MedicineOncologyPathology and Forensic Medicine2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Esophageal Cancer Research and Treatment Surgery 10 works
  2. 2 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 9 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 8 works
  4. 4 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 4 works
  5. 5 Colorectal Cancer Treatments and Studies Oncology 4 works
  6. 6 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 3 works
  7. 7 Cancer Genomics and Diagnostics Cancer Research 3 works
  8. 8 Genetic factors in colorectal cancer Pathology and Forensic Medicine 3 works
  9. 9 Pancreatic and Hepatic Oncology Research Oncology 3 works
  10. 10 Chronic Lymphocytic Leukemia Research Genetics 2 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.2%not open60.8%

World: 40% of research is openly available.

with international co-authors7.8%domestic only92.2%

World: 18% is written across borders.

How has Saitama Cancer Center's research output changed?

Output in 2022-2025 was 15% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Saitama Cancer Center as a percentage of every work published that year, 0.00068% in 2024.

still counting0.0025%0.0050%0.0075%Saitama Cancer Center0.00074% in 202519801990200020102020

Fractional works of Saitama Cancer Center over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

still counting10%20%all institutions10.0% in 2025Saitama Cancer Center6.0% in 2025200020102020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 19.5% in 1991.

Other research institutions in Saitama

All research institutions in Saitama

Share Saitama Cancer Center's ranking

Saitama Cancer Center on Science Explorer

A card with Saitama Cancer Center's standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Saitama Cancer Center. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.